The curability of immune hemolysis is related to the cause of the hemolysis.
Immune hemolysis, or autoimmune hemolytic anemia, can be divided into primary and secondary. Primary autoimmune hemolytic anemia is associated with genetic factors. Secondary autoimmune hemolytic anemia is mostly related to infections, lymphatic system tumors, connective tissue diseases, malignant tumors, and the use of certain drugs.
Primary autoimmune hemolytic anemia, generally can not be cured, the principle of treatment is mainly symptomatic treatment, such as correcting anemia, diuretic yellowing, correcting the water-electrolyte balance disorders, the application of immunosuppressive drugs.
Autoimmune hemolytic anemia secondary to infection can be cured after active anti-infection treatment.
Autoimmune hemolytic anemia caused by lymphatic system tumor, connective tissue disease, malignant tumor, etc., the cure rate is low, mainly symptomatic treatment, plasma replacement, splenectomy, etc. if necessary.
Autoimmune hemolytic anemia caused by drugs, after stopping the drugs, take symptomatic treatment, generally can be cured.
Whether immune hemolytic anemia can be cured is also related to the individual’s physical condition, the stage of the disease, and the treatment method, etc. It is recommended that the cause of the disease be clarified and the prognosis be evaluated with the help of a doctor.